1. Gul H, Erdem H. Brucellosis (Brucella species) In:Mandell GL,Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases.Philadelphia: Churchill Livingstone, 2020:2753-2758.
2. Serap Şimşek Yavuz. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Derneği Kanıta Dayalı Bruselloz Tanı ve Tedavi Klinik Uygulama Rehberi, 2023. KLİMİK DERGİSİ. 2023;36(2):86–
123.
3. Wyatt HP. Lessons from the history of brucellosis: -EN- -FR- -ES-. Rev Sci Tech OIE. 2013 Apr 1;32(1):17–25.
4. Whatmore AM, Foster JT. Emerging diversity and ongoing expansion of the genus Brucella. Infect Genet Evol. 2021 Aug;92:104865. doi: 10.1016/j.meegid.2021.104865. Epub 2021 Apr 17.
PMID: 33872784.
5. Yang Z, Chai Z, Wang X, Zhang Z, Zhang F, Kang F, et al. Comparative genomic analysis provides insights into the genetic diversity and pathogenicity of the genus Brucella. Front Microbiol.
2024 Apr 24;15:1389859.
6. Yang Z, Chai Z, Wang X, Zhang Z, Zhang F, Kang F, et al. Comparative genomic analysis provides insights into the genetic diversity and pathogenicity of the genus Brucella. Front Microbiol.
2024 Apr 24;15:1389859.
7. Occhialini A, Hofreuter D, Ufermann CM, Al Dahouk S, Köhler S. The Retrospective on Atypical Brucella Species Leads to Novel Definitions. Microorganisms. 2022 Apr 14;10(4):813.
8. Moreno E, Middlebrook EA, Altamirano-Silva P, Al Dahouk S, Araj GF, Arce-Gorvel V, et al. If You’re Not Confused, You’re Not Paying Attention: Ochrobactrum Is Not Brucella. J Clin
Microbiol. 2023 Aug 23;61(8):e0043823.
9. Qureshi KA, Parvez A, Fahmy NA, Abdel Hady BH, Kumar S, Ganguly A, et al. Brucellosis: epidemiology, pathogenesis, diagnosis and treatment-a comprehensive review. Ann Med.
2023;55(2):2295398.
10. Freddi L, de la Garza-García JA, Al Dahouk S, Occhialini A, Köhler S. Brucella spp. are facultative anaerobic bacteria under denitrifying conditions. Microbiol Spectr. 11(6):e02767-23.
11. Kurmanov B, Zincke D, Su W, Hadfield TL, Aikimbayev A, Karibayev T, et al. Assays for Identification and Differentiation of Brucella Species: A Review. Microorganisms. 2022 Aug
6;10(8):1584.
12. Roop RM, Barton IS, Hopersberger D, Martin DW. Uncovering the Hidden Credentials of Brucella Virulence. Microbiol Mol Biol Rev. 85(1):e00021-19.
13. Laine CG, Scott HM, Arenas-Gamboa AM. Human brucellosis: Widespread information deficiency hinders an understanding of global disease frequency. PLoS Negl Trop Dis. 2022 May
17;16(5):e0010404.
14. The European Union One Health 2022 Zoonoses Report – PMC [Internet]. [cited 2024 May 21]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10714251/
15. Djokic V, Freddi L, de Massis F, Lahti E, van den Esker MH, Whatmore A, et al. The emergence of Brucella canis as a public health threat in Europe: what we know and what we need to learn.
Emerg Microbes Infect. 12(2):2249126.
16. Brucellosis – Annual epidemiological report. 2022 [cited 2024 May 21]; Available from: https://www.ecdc.europa.eu/sites/default/files/documents/BRUC_AER_2022_Report.pdf
17. Tuon FF, Gondolfo RB, Cerchiari N. Human-to-human transmission of Brucella – a systematic review. Trop Med Int Health. 2017 May;22(5):539–46.
18. de Figueiredo P, Ficht TA, Rice-Ficht A, Rossetti CA, Adams LG. Pathogenesis and Immunobiology of Brucellosis. Am J Pathol. 2015 Jun;185(6):1505–17.
19. Barquero-Calvo E, Chaves-Olarte E, Weiss DS, Guzmán-Verri C, Chacón-Díaz C, Rucavado A, et al. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system
during the onset of infection. PLoS One. 2007 Jul 18;2(7):e631.
20. Pascual DW, Goodwin ZI, Bhagyaraj E, Hoffman C, Yang X. Activation of mucosal immunity as a novel therapeutic strategy for combating brucellosis. Front Microbiol. 2022;13:1018165.
21. Dadelahi AS, Abushahba MFN, Ponzilacqua-Silva B, Chambers CA, Moley CR, Lacey CA, et al. Interactions between B cells and T follicular regulatory cells enhance susceptibility to Brucella
infection independent of the anti-Brucella humoral response. PLoS Pathog. 2023 Sep 18;19(9):e1011672.
22. Liu B, Liu G, Ma X, Wang F, Zhang R, Zhou P, et al. Epidemiology, clinical manifestations, and laboratory findings of 1,590 human brucellosis cases in Ningxia, China. Front Microbiol. 2023
Nov 27;14:1259479.
23. Corbel MJ, Food and Agriculture Organization of the United Nations, World Health Organization, World Organisation for Animal Health. Brucellosis in humans and animals. 2006 [cited
2024 May 22];(WHO/CDS/EPR/2006.7). Available from: https://iris.who.int/handle/10665/43597
24. Erdem H, Baymakova M, Alkan S, Letaief A, Yahia WB, Dayyab F, et al. Classical fever of unknown origin in 21 countries with different economic development: an international ID-IRI study.
Eur J Clin Microbiol Infect Dis. 2023 Apr;42(4):387–98.
25. Jin M, Fan Z, Gao R, Li X, Gao Z, Wang Z. Research progress on complications of Brucellosis. Front Cell Infect Microbiol. 2023 Mar 31;13:1136674.
26. Spernovasilis N, Karantanas A, Markaki I, Konsoula A, Ntontis Z, Koutserimpas C, et al. Brucella Spondylitis: Current Knowledge and Recent Advances. J Clin Med. 2024 Jan 19;13(2):595.
27. Ulu-Kilic A, Karakas A, Erdem H, Turker T, Inal AS, Ak O, et al. Update on treatment options for spinal brucellosis. Clinical Microbiology and Infection. 2014 Feb 1;20(2):O75–82.
28. Esmaeilnejad-Ganji SM, Esmaeilnejad-Ganji SMR. Osteoarticular manifestations of human brucellosis: A review. World J Orthop. 2019 Feb 18;10(2):54–62.
29. Giambartolomei GH, Delpino MV. Immunopathogenesis of Hepatic Brucellosis. Frontiers in Cellular and Infection Microbiology [Internet]. 2019 [cited 2024 May 24];9. Available from:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951397/
30. Batirel A, Regmi SK, Singh P, Mert A, Konety BR, Kumar R. Urological infections in the developing world: an increasing problem in developed countries. World J Urol. 2020 Nov;38(11):2681–
91.
31. Erdem H, Inan A, Elaldi N, Tekin R, Gulsun S, Ataman-Hatipoglu C, et al. Respiratory System Involvement in Brucellosis: The Results of the Kardelen Study. CHEST. 2014 Jan 1;145(1):87–94.
32. Soares CN, da Silva MTT, Lima MA. Neurobrucellosis. Current Opinion in Infectious Diseases. 2023 Jun;36(3):192.
33. Tajerian A, Sofian M, Zarinfar N, Ramezani A. Manifestations, complications, and treatment of neurobrucellosis: a systematic review and meta-analysis. Int J Neurosci. 2024 Jun;134(3):256–
66.
34. Narimisa N, Razavi S, Khoshbayan A, Masjedian Jazi F. Prevalence of Brucella endocarditis: A systematic review and meta‐analysis. Health Sci Rep. 2023 May 25;6(5):e1301.
35. Turk Klinik Mikrobiyoloji ve Infeksiyon Hastaliklari Dernegi Infektif Endokardit ve Diger Kardiyovaskuler Infeksiyonlar Calisma Grubu Istanbul, Turkiye, Simsek-Yavuz S, Akar AR, Turk
Kalp ve Damar Cerrahisi Dernegi (Ankara Universitesi, Ankara Sehir Hastanesi, Dr. Siyami Ersek Gogus Kalp ve Damar Cerrahisi Egitim ve Arastirma Hastanesi), Istanbul, Turkiye, Aydogdu
S, Turk Kardiyoloji Dernegi (Ankara Sehir Hastanesi, Hacettepe Universitesi, Dokuz Eylul Universitesi), Istanbul, Turkiye, et al. Diagnosis, Treatment and Prevention of Infective Endocarditis:
Turkish Consensus Report. Klimik Dergisi. 2019 Sep 20;32(Supp1):2–116.
36. Willems SA, Brouwers JJWM, Eefting D. Aortic and Iliac Involvement in Brucellosis – A Rare but Life Threatening Manifestation: A Review of the Literature. European Journal of Vascular
and Endovascular Surgery. 2022 May 1;63(5):743–50.
37. Kaman A, Öz FN, Fettah A, Durmuş SY, Teke TA, Tanır G. Clinicoepidemiological findings of childhood brucellosis in a tertiary care center in Central Anatolia: with the emphasis of hema-
tological findings. The Turkish Journal of Pediatrics. 2022 Feb 25;64(1):10–8.
38. Evlice O, Çeviker SA, Filik A, Ağın A. Ocular Involvement of Brucellosis: A Pooled Analysis Study. Ocul Immunol Inflamm. 2023 Oct;31(8):1677–86.
39. Inan A, Erdem H, Elaldi N, Gulsun S, Karahocagil MK, Pekok AU, et al. Brucellosis in pregnancy: results of multicenter ID-IRI study. Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1261–8.
40. Yagupsky P, Morata P, Colmenero JD. Laboratory Diagnosis of Human Brucellosis. Clinical Microbiology Reviews. 2019 Nov 13;33(1):10.1128/cmr.00073-19.
41. İrvem A, Yücel FM, Aksaray S, Bor E. [Comparison of a new and rapid method, Brucella Coombs gel test with the other methods in the serological diagnosis of brucellosis]. Mikrobiyol Bul.
2015 Apr;49(2):181–7.
42. Uysal B, Mumcu N, Yıldız O, Aygen B. Comparison of the Methods Used in the Diagnosis of Brucellosis. Klimik Derg. 2021 Nov 10;34(3):164–73.
43. Shome R, Patra S, Sahib MM, Shanmugam G, Dubey S, Skariah S, et al. Evaluation of an in-house IgM/IgG lateral flow assay for serodiagnosis of human brucellosis. Indian J Med Microbiol.
2023;42:55–8.
44. Moradkasani S, Goodarzi F, Beig M, Tadi DA, Sholeh M. Prevalence of Brucella melitensis and Brucella abortus aminoglycoside-resistant isolates: a systematic review and meta-analysis. Braz
J Microbiol. 2024 Mar;55(1):429–39.
45. Rezaei Shahrabi A, Moradkasani S, Goodarzi F, Beig M, Sholeh M. Prevalence of Brucella melitensis and Brucella abortus tetracyclines resistance: A systematic review and meta-analysis.
Microb Pathog. 2023 Oct;183:106321.
46. Beig M, Moradkasani S, Goodarzi F, Sholeh M. Prevalence of Brucella melitensis and Brucella abortus Fluoroquinolones Resistant Isolates: A Systematic Review and Meta-Analysis. Vector
Borne Zoonotic Dis. 2024 Jan;24(1):1–9.
47. Arapović J, Kompes G, Dedić K, Teskeredžić S, Ostojić M, Travar M, et al. Antimicrobial resistance profiles of human Brucella melitensis isolates in three different microdilution broths: the
first multicentre study in Bosnia and Herzegovina. J Glob Antimicrob Resist. 2022 Jun;29:99–104.
48. Gültekin E, Uyanık MH, Albayrak A, Kılıç S. Investigation of antibiotic susceptibilities of Brucella Strains isolated from various clinical samples in eastern Turkey. European Journal of Medical
Research. 2021 Jun 16;26(1):57.